Skip to main content

Table 3 Prediction of composite cardiac events in patients with NICM (model 2)

From: Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non‐ischemic cardiomyopathy

 

HR (95 % CIs)

p-value

12-Month follow-up BNP

1.003 (1.001–1.006)

0.010

12-Month follow-up LVEDV

1.090 (0.985–1.236)

0.142

12-Month follow-up LVESV

0.894 (0.735–1.049)

0.220

12-Month follow-up LVEF

0.858 (0.617–1.123)

0.321

Non LVRR

5.85 (1.19–35.23)

0.030

  1. BNP brain natriuretic peptide, CIs confidence intervals, HR hazard ratio, LVEDV left ventricular end-diastolic volume, LVEF left ventricular ejection fraction, LVESV left ventricular end-systolic volume, LVRR left ventricular reverse remodeling, NICM non-ischemic cardiomyopathy